Lianhuan Pharmaceutical released its report for the first quarter of 2024, achieving operating income of 528 million yuan, a year-on-year increase of 17%; net profit attributable to shareholders of listed companies of 32.5454 million yuan, an increase of 4.58% over the previous year; and basic earnings per share of 0.11 yuan.
联环药业：一季度净利润同比增长4.58%
Lianhuan Pharmaceutical: Net profit increased 4.58% year-on-year in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.